Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 28.3 USD -0.63% Market Closed
Market Cap: 874.8m USD
Section:
 

Relative Value

The Relative Value of one FLGT stock under the Base Case scenario is 20.27 USD. Compared to the current market price of 28.3 USD, Fulgent Genetics Inc is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLGT Relative Value
Base Case
20.27 USD
Overvaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
30
vs Industry
49
Median 3Y
2.3
Median 5Y
2.4
Industry
2.3
Forward
2.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-11.2
Median 5Y
-3.7
Industry
22.5
Forward
-80.7
More Details
573.3
P/OCF
P/OCF
Price to OCF
573.3
vs History
1
vs Industry
14
Median 3Y
19.4
Median 5Y
15.5
Industry
14.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
-13.8
Median 5Y
3.8
Industry
21.6
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
49
vs Industry
77
Median 3Y
0.6
Median 5Y
0.8
Industry
2.2
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
33
vs Industry
68
Median 3Y
1.1
Median 5Y
1.3
Industry
2.6
Forward
1.5
More Details
3.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.8
vs History
22
vs Industry
63
Median 3Y
2.9
Median 5Y
2.9
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-1.9
Industry
12
Forward
-20.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-1.6
Industry
17
Forward
-11.8
More Details
327.9
EV/OCF
EV/OCF
Enterprise Value to OCF
327.9
vs History
1
vs Industry
30
Median 3Y
10.1
Median 5Y
7.5
Industry
14.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
23
Median 3Y
2.2
Median 5Y
3.2
Industry
18.7
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
49
vs Industry
83
Median 3Y
0.4
Median 5Y
0.6
Industry
1.9
More Details

Multiples Across Competitors

FLGT Competitors Multiples
Fulgent Genetics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Fulgent Genetics Inc
NASDAQ:FLGT
873.2m USD 2.8 -20.3 -10.7 -7
US
CVS Health Corp
NYSE:CVS
97.5B USD 0.2 207.8 13.8 13.8
US
Cigna Group
XMUN:CGN
61.9B EUR 0.3 11.7 7.6 9.6
US
Cigna Corp
NYSE:CI
71.6B USD 0.3 11.6 7.5 9.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.2B EUR 1.2 23.7 10.4 15.8
DE
Fresenius Medical Care AG
XMUN:FME
23.8B EUR 1.2 33 10.4 22.2
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 1.6 25.4 13.8 19.2
US
Quest Diagnostics Inc
NYSE:DGX
20.4B USD 1.9 21.2 11.7 15.8
US
Guardant Health Inc
NASDAQ:GH
13.6B USD 15 -34 -35.8 -32.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 16.1 6.4 13.6
US
Hims & Hers Health Inc
NYSE:HIMS
9.1B USD 4.1 68.1 54.2 71.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Fulgent Genetics Inc
NASDAQ:FLGT
Average EV/EBITDA: 15.1
Negative Multiple: -10.7 		N/A N/A
US
CVS Health Corp
NYSE:CVS
13.8
25%
0.6
US
C
Cigna Group
XMUN:CGN
7.6
5%
1.5
US
Cigna Corp
NYSE:CI
7.5
5%
1.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.4
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
10.4
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
13.8
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
11.7
8%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -35.8 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.4
10%
0.6
US
Hims & Hers Health Inc
NYSE:HIMS
54.2
83%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Fulgent Genetics Inc
NASDAQ:FLGT
Average EV/EBIT: 21.2
Negative Multiple: -7 		N/A N/A
US
CVS Health Corp
NYSE:CVS
13.8
18%
0.8
US
C
Cigna Group
XMUN:CGN
9.6
6%
1.6
US
Cigna Corp
NYSE:CI
9.6
6%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
22.2
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.8
11%
1.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -32.5 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.6
25%
0.5
US
Hims & Hers Health Inc
NYSE:HIMS
71.7
63%
1.1

See Also

Summary
FLGT intrinsic value, competitors valuation, and company profile.
DCF Valuation
FLGT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FLGT stock valuation using valuation multiples.
Wall Street Estimates
FLGT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FLGT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.